For: | Davis J, Chun AK, Borum ML. Could there be light at the end of the tunnel? Mesocaval shunting for refractory esophageal varices in patients with contraindications to transjugular intrahepatic portosystemic shunt. World J Hepatol 2016; 8(19): 790-795 [PMID: 27429715 DOI: 10.4254/wjh.v8.i19.790] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v8/i19/790.htm |
Number | Citing Articles |
1 |
Lucas H. P. Bernts, Joost P. H. Drenth, Eric T. T. L. Tjwa. Management of portal hypertension and ascites in polycystic liver disease. Liver International 2019; 39(11): 2024 doi: 10.1111/liv.14245
|
2 |
Ishan Sinha, Daryl T. Goldman, Rahul S. Patel, Francis S. Nowakowski. Endovascular Alternatives to Transhepatic Shunt Creation. Seminars in Interventional Radiology 2023; 40(01): 073 doi: 10.1055/s-0043-1767687
|
3 |
Ja Kyung Yoon, Man-Deuk Kim, Do Yun Lee, Seok Joo Han. Mesocaval Shunt Creation for Jejunal Variceal Bleeding with Chronic Portal Vein Thrombosis. Yonsei Medical Journal 2018; 59(1): 162 doi: 10.3349/ymj.2018.59.1.162
|
4 |
Yashwant Patidar, Sushant Babbar, Amar Mukund, Shiv Kumar Sarin. Transjugular Intrahepatic Portosystemic Shunt (TIPS) Extension for Transhepatic Mesocaval Shunt Creation: A Case Series for Treating Refractory Upper Gastrointestinal Bleeding in Patients with Chronic Portal Vein Thrombosis. Indian Journal of Radiology and Imaging 2024; 34(02): 335 doi: 10.1055/s-0043-1777321
|
5 |
Max Kabolowsky, Lyndsey Nguyen, Brett E. Fortune, Ernesto Santos, Sirish Kishore, Juan C. Camacho. Interventional Management of Portal Hypertension in Cancer Patients. Current Oncology Reports 2022; 24(11): 1461 doi: 10.1007/s11912-022-01319-8
|
6 |
Indrani Sen, Lavanya Yohanathan, Jussi M. Kärkkäinen, David M. Nagorney. Current Indications and Long-Term Outcomes of Surgical Portosystemic Shunts in Adults. Journal of Gastrointestinal Surgery 2021; 25(6): 1437 doi: 10.1007/s11605-020-04643-1
|